BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Warner BM, Santry LA, Leacy A, Chan M, Pham PH, Vendramelli R, Pei Y, Tailor N, Valcourt E, Leung A, He S, Griffin BD, Audet J, Willman M, Tierney K, Albietz A, Frost KL, Yates JGE, Mould RC, Chan L, Mehrani Y, Knapp JP, Minott JA, Banadyga L, Safronetz D, Wood H, Booth S, Major PP, Bridle BW, Susta L, Kobasa D, Wootton SK. Intranasal vaccination with a Newcastle disease virus-vectored vaccine protects hamsters from SARS-CoV-2 infection and disease. iScience 2021;24:103219. [PMID: 34632328 DOI: 10.1016/j.isci.2021.103219] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
Number Citing Articles
1 Yang T, Chen Y, Xu Y, Liu X, Yang M, Mao C. Viruses as biomaterials. Materials Science and Engineering: R: Reports 2023;153:100715. [DOI: 10.1016/j.mser.2023.100715] [Reference Citation Analysis]
2 Minott JA, van Vloten JP, Yates JGE, Chan L, Wood GA, Viloria-petit AM, Karimi K, Petrik JJ, Wootton SK, Bridle BW. Multiplex flow cytometry-based assay for quantifying tumor- and virus-associated antibodies induced by immunotherapies. Front Immunol 2022;13. [DOI: 10.3389/fimmu.2022.1038340] [Reference Citation Analysis]
3 Choudhary OP, Priyanka, Saied AA. COVID-19 vaccination in animals: A strategy for combating the global outbreak. Int J Surg 2022;105:106848. [PMID: 36028140 DOI: 10.1016/j.ijsu.2022.106848] [Reference Citation Analysis]
4 de Swart RL, de Leeuw OS, Oreshkova N, Gerhards NM, Albulescu IC, Vreman S, Gonzales JL, Maas R, van Kuppeveld FJM, Soema P, Bosch BJ, Peeters BPH. Intranasal administration of a live-attenuated recombinant newcastle disease virus expressing the SARS-CoV-2 Spike protein induces high neutralizing antibody levels and protects from experimental challenge infection in hamsters. Vaccine 2022:S0264-410X(22)00856-8. [PMID: 35820941 DOI: 10.1016/j.vaccine.2022.07.005] [Reference Citation Analysis]
5 Deschambault Y, Lynch J, Warner B, Tierney K, Huynh D, Vendramelli R, Tailor N, Frost K, Sajesh B, LeBlanc K, Layne C, Lin L, Tamming L, Beniac D, Booth S, Carpenter M, Safronetz D, Li X, Kobasa D, Cao J. Single Immunization with Recombinant ACAM2000 Vaccinia Viruses Expressing the Spike and the Nucleocapsid Proteins Protects Hamsters against SARS-CoV-2-Caused Clinical Disease. J Virol 2022;96:e0038922. [PMID: 35412347 DOI: 10.1128/jvi.00389-22] [Reference Citation Analysis]
6 Fulber JPC, Kamen AA. Development and Scalable Production of Newcastle Disease Virus-Vectored Vaccines for Human and Veterinary Use. Viruses 2022;14:975. [DOI: 10.3390/v14050975] [Reference Citation Analysis]
7 Alu A, Chen L, Lei H, Wei Y, Tian X, Wei X. Intranasal COVID-19 vaccines: From bench to bed. EBioMedicine 2022;76:103841. [PMID: 35085851 DOI: 10.1016/j.ebiom.2022.103841] [Cited by in Crossref: 80] [Cited by in F6Publishing: 74] [Article Influence: 80.0] [Reference Citation Analysis]
8 Fulber JPC, Farnós O, Kiesslich S, Yang Z, Dash S, Susta L, Wootton SK, Kamen AA. Process Development for Newcastle Disease Virus-Vectored Vaccines in Serum-Free Vero Cell Suspension Cultures. Vaccines (Basel) 2021;9:1335. [PMID: 34835266 DOI: 10.3390/vaccines9111335] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]